Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)

Overview of attention for article published in Journal of Hematology & Oncology, February 2013

Altmetric Badge

About this Attention Score

So far, Dimensions has found 30 publications that cite this research output.

Article in Current Hematologic Malignancy Reports (May 2022)

Article in Blood Advances (January 2022)

Article in Seminars in Hematology (January 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.